What is the Share Price of Medico Remedies Ltd?
- Answer Field
-
The share price of Medico Remedies Ltd for NSE is ₹ 55.66 and for BSE is ₹ 55.47.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, MEDICO REMEDIES LIMITED share price is currently at ₹ 55.66, which is down by ₹ -0.86 from its previous closing. Today, the stock has fluctuated between ₹ 54.59 and ₹ 58.00. Over the past year, MEDICO REMEDIES LIMITED has achieved a return of 22.59 %. In the last month alone, the return has been 4.42 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 39.49 |
Operating Expense | 37.42 |
Net Profit | 2.62 |
Net Profit Margin (%) | 6.63 |
Earnings Per Share (EPS) | 0.32 |
EBITDA | 4.54 |
Effective Tax Rate (%) | 25.14 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 19.60 | 1.99 | 279.41 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 119.00 | 15.60 | 1.24 | 1253.91 | 92.25 / 184.95 |
CIPLA LTD | 1549.65 | 25.08 | 4.41 | 125155.99 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 260.70 | 21.60 | 2.64 | 767.27 | 145.00 / 449.00 |
GLAXOSMITHKLINE PHARMA LT | 2959.45 | 58.70 | 29.97 | 50134.87 | 1924.30 / 3147.45 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 21.96 | 6.19 | 279.41 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 692.80 | 40.61 | 6.72 | 2002.93 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8665.50 | 129.24 | 31.88 | 21663.75 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 119.00 | 15.45 | 1.22 | 1253.91 | 92.25 / 184.95 |
Medico Remedies Limited was incorporated as a Private Limited Company with the name 'Medico Remedies Private Limited' on March 18, 1994. The status was changed to a Public Limited Company and the Company name was changed to Medico Remedies Limited on March 6, 2017.
Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. Further in addition to above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, Antihistaminic, Antidiabetics, Cardio Vascular Drugs, Diuretics, Anti-Epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.
The Company is ISO 9001:2015 certified for its management system for the manufacture and marketing of pharmaceutical products. It also obtained a WHO-GMP accreditation for the manufacture of its products from the World Health Organisation and has also been certified by Government Recognised Star Exports, Pharmacy and Poison Board, NAFDAC and National Drug Authority, Uganda.
The Company began its operations in 1994 with manufacturing and servicing of diuretics, anti-malarials, NSAIDS tablets, anti-reterovirals, anti-ulcer drugs and anti-acids tablets. Over the years the company has expanded its scale and scope of operations and currently the Company is engaged in manufacture of formulations for various medicines. As part of this expansion, in year 1999 & 2002, Company has a manufacturing facility for the manufacture of its products located in the State of Maharashtra at Palghar.. The plant is divided into two units, i.e. general formulations unit and beta-lactam unit; the beta lactam unit is further divided into two segments -Penicillin and Cephalosporins.
The Company has built a strong relationship with its customers for drug formulations. The clients include Indian as well as foreign pharmaceutical companies like Anphar Limited, Saad Medical, Manfes Pharmaceuticals & Chemical Industries, Award Global Company Limited, Directorate of Health Services (DHS, Maharashtra) to name a few. The Company also earns revenue from the sale of licenses such as FMS license, FPS license and MESI license.
In 2018-19, the Company purchased adjoining manufacturing unit with existing factory at Palghar.
In January 2018, the Company came up with a Public Issue of 10,99,200 Equity Shares by raising equity capital amounting to Rs 10.99 Crores.
The share price of Medico Remedies Ltd for NSE is ₹ 55.66 and for BSE is ₹ 55.47.
The market cap of Medico Remedies Ltd for NSE is ₹ 4,61.90 Cr. and for BSE is ₹ 0.0 Cr. as of now.
The 52 Week High and Low of Medico Remedies Ltd for NSE is ₹ 79.83 and ₹ 34.80 and for BSE is ₹ 79.78 and ₹ 35.00.
You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 22.59%.
Medico Remedies Ltd share price is for NSE ₹ 55.66 & for BSE ₹ 55.47 as on Apr 30 2025 03:30 PM.
The market cap of Medico Remedies Ltd for NSE ₹ 4,61.90 & for BSE ₹ 0.0 as on Apr 30 2025 03:30 PM.
As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Medico Remedies Ltd share is 51.86.
As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Medico Remedies Ltd share is 6.68.
You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a demat account.
To buy Medico Remedies Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Medico Remedies Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found